Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 440915
Gene Symbol: POTEKP
POTEKP
0.010 Biomarker phenotype BEFREE I-ACT primarily aims to examine objectively measured PA levels and patterns in first and second trimesters of pregnancy and the association with GDM and/or GH in Singapore, a multiethnic Asian population. 30948592 2019
Entrez Id: 406979
Gene Symbol: MIR19A
MIR19A
0.010 Biomarker phenotype BEFREE MicroRNA-19a and 19b have been linked to alcoholism and smoking and could also be the factors in GDM. 31687318 2019
Entrez Id: 9242
Gene Symbol: MSC
MSC
0.010 AlteredExpression phenotype BEFREE Our results reveal that Netrin-1 is secreted by WJ-MSC from healthy and GDM and both expression and secretion of the ligand do not change with distinct experimental glucose conditions. 30897795 2019
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.010 AlteredExpression phenotype BEFREE VCAM-1, PAI-1, and COX-2 expression was higher in HUVECs from patients with GDM than the controls. 31061324 2019
Entrez Id: 9034
Gene Symbol: CCRL2
CCRL2
0.010 Biomarker phenotype BEFREE Targeting CCRL2 and/or ChemR23 could be useful for treating neuropsychological deficits in offspring of dams with diabetes in pregnancy. 31733653 2019
Entrez Id: 407010
Gene Symbol: MIR23A
MIR23A
0.010 GeneticVariation phenotype BEFREE Two upregulated microRNAs (miR-223 and miR-23a) were identified in GDM vs the control set, and validated on a new cohort of women. 31539877 2019
Entrez Id: 7448
Gene Symbol: VTN
VTN
0.010 Biomarker phenotype BEFREE Vitronectin was shown to contribute significantly to the predictive power of the maternal risk factors, indicating it as a novel independent predictor of GDM. 30917176 2019
Entrez Id: 10724
Gene Symbol: OGA
OGA
0.010 AlteredExpression phenotype BEFREE Total renal volume, cortical volume, and urinary activity of N-acetyl-β-D-glucosaminidase and cathepsin B may be suggested as indicators for the early recognition of GDM neonates at long-term risk of hypertension and kidney disease. 30925803 2019
Entrez Id: 7373
Gene Symbol: COL14A1
COL14A1
0.010 AlteredExpression phenotype BEFREE Quantitative proteomic analysis, based on LC-MS<sup>E</sup> approach, revealed that higher (approximately 15% increase) levels of galectin 1 and collagen alpha-1 XIV chain (although the difference regarding the latter was at the limit of significance) were present in GDM samples, while heat shock 70 kDa protein 1A/1B was less abundant in GDM placental tissue. 30675960 2019
Entrez Id: 3973
Gene Symbol: LHCGR
LHCGR
0.010 GeneticVariation phenotype BEFREE Rates of gestational diabetes mellitus (GDM) (P = 0.007) and female neonates (P = 0.001) were significantly higher in the LHG group compared with the HHG group; no significant differences were observed in the low versus high HCG group overall. 30660603 2019
Entrez Id: 983
Gene Symbol: CDK1
CDK1
0.010 Biomarker phenotype BEFREE KIF2C, CENPE, CCNA2, AURKB, MAD2L1, CCNB2, CDC20, PLK1, CCNB1, and CDK1 all have degree larger than 50 and MM larger than 0.9, so they might be valuable biomarkers in GDM. 30474315 2019
Entrez Id: 3487
Gene Symbol: IGFBP4
IGFBP4
0.010 Biomarker phenotype BEFREE Pregnant women with GDM had decreased mRNA expression of IGF-1, IGF-1R and IGF-2R and IGFBP-4 in VAT and IGF-1R in SAT compared to pregnant women without GDM. 31424259 2019
Entrez Id: 2152
Gene Symbol: F3
F3
0.010 AlteredExpression phenotype BEFREE There was a significant increase in EGR-1 and TF levels in HuVECs isolated form GDM mother's umbilical cord and normal HuVECs treated with high glucose condition. 30767098 2019
Entrez Id: 11332
Gene Symbol: ACOT7
ACOT7
0.010 Biomarker phenotype BEFREE I-ACT primarily aims to examine objectively measured PA levels and patterns in first and second trimesters of pregnancy and the association with GDM and/or GH in Singapore, a multiethnic Asian population. 30948592 2019
Entrez Id: 10725
Gene Symbol: NFAT5
NFAT5
0.010 Biomarker phenotype BEFREE Nuclear NFAT5 was also increased in the GDM placenta. 31647034 2019
Entrez Id: 219699
Gene Symbol: UNC5B
UNC5B
0.010 AlteredExpression phenotype BEFREE Noteworthy, the expression of its anti-angiogenic receptor UNC5b is reduced in GDM HUVEC compared with its expression in healthy HUVEC, accounting for an increased Netrin-1 signalling in these cells. 30897795 2019
Entrez Id: 1240
Gene Symbol: CMKLR1
CMKLR1
0.010 Biomarker phenotype BEFREE Targeting CCRL2 and/or ChemR23 could be useful for treating neuropsychological deficits in offspring of dams with diabetes in pregnancy. 31733653 2019
Entrez Id: 442910
Gene Symbol: MIR345
MIR345
0.010 Biomarker phenotype BEFREE Compared with pregnant women without GDM, lncRNA MEG3 levels were significantly elevated in the blood and placental villous tissues of GDM pregnant women. miR-345-3p was identified to be a direct target of lncRNA MEG3 using dual luciferase reporter assay, which was found to be reduced in pregnant women with GDM. 31656536 2019
Entrez Id: 8639
Gene Symbol: AOC3
AOC3
0.010 Biomarker phenotype BEFREE Hence, we think that VAP-1 could be a promising marker for the prediction of gestational diabetes. 31638437 2019
Entrez Id: 345
Gene Symbol: APOC3
APOC3
0.010 Biomarker phenotype BEFREE High Apo CIII levels and the Apo CIII/Apo AI, Apo CIII/Apo AII, Apo CIII/Apo CII, and Apo CIII/Apo E ratios are all significant risk factors for the development of type 2 diabetes in women with a previous GDM pregnancy. 29529691 2019
Entrez Id: 724027
Gene Symbol: MIR657
MIR657
0.010 Biomarker phenotype BEFREE Accordingly, dysregulation of miR-657 contributes to the pathogenesis of GDM via IL-37/NF-κB signaling axis. 30362558 2019
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.010 Biomarker phenotype BEFREE I-ACT primarily aims to examine objectively measured PA levels and patterns in first and second trimesters of pregnancy and the association with GDM and/or GH in Singapore, a multiethnic Asian population. 30948592 2019
Entrez Id: 158038
Gene Symbol: LINGO2
LINGO2
0.010 GeneticVariation phenotype BEFREE These findings indicate that LINGO2 rs824248 may serve as a susceptibility marker for GDM in Chinese females. 30426492 2019
Entrez Id: 7433
Gene Symbol: VIPR1
VIPR1
0.010 Biomarker phenotype BEFREE This pilot study aimed to examine whether the expression of the high mobility group box 1 protein (HMGB1) and its receptor for advanced glycation end products (RAGE), and the vasoactive intestinal peptide (VIP) and its receptors (VPAC-1,-2) were modified in pregnant women with GDM. 30820673 2019
Entrez Id: 259
Gene Symbol: AMBP
AMBP
0.010 GeneticVariation phenotype BEFREE Obstetric complications included gestational hypertension (9.5%), gestational diabetes (6.0%), and UTI (53.5%), of which 84.5% reported treatment. 31109301 2019